PubRank

G Botti

Author PubWeight™ 84.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evaluation of the Unified Medical Language System as a medical knowledge source. J Am Med Inform Assoc 1998 3.15
2 In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients. Eur J Nucl Med 1997 2.15
3 Methodology for using the UMLS as a background knowledge for the description of surgical procedures. Int J Biomed Comput 1996 1.89
4 A system that facilitates the orientation within procedure nomenclatures through a semantic approach. Med Inform (Lond) 1995 1.82
5 Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007 1.61
6 [A study of 82 cerebral infarctions in the area of posterior cerebral arteries]. Rev Neurol (Paris) 1994 1.55
7 Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 1995 1.44
8 Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer. Cancer Res 1999 1.38
9 [Recording of monophasic action potentials of the right ventricle in a case of long QT and isolated alternation of the U wave]. Arch Mal Coeur Vaiss 1979 1.38
10 Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer 2001 1.31
11 Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. Cancer Res 2000 1.30
12 Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res 1998 1.29
13 Juvenile nasopharyngeal angiofibroma: comparison of blood loss during removal in embolized group versus nonembolized group. Cardiovasc Intervent Radiol 1995 1.26
14 A Web terminology server using UMLS for the description of medical procedures. J Am Med Inform Assoc 1997 1.22
15 Morbidity of major hepatic resections: a 100-case prospective study. Eur J Surg 1999 1.12
16 WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors. Oncol Rep 2010 1.09
17 Lysyl oxidase activates the transcription activity of human collagene III promoter. Possible involvement of Ku antigen. J Biol Chem 2000 1.08
18 Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies. Cancer Res 1994 1.08
19 The non-pathogenic Australian lagovirus RCV-A1 causes a prolonged infection and elicits partial cross-protection to rabbit haemorrhagic disease virus. Virology 2010 1.07
20 Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003 1.06
21 BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy. Cell Death Dis 2012 1.05
22 An assessment of delays in obtaining definitive breast cancer treatment in Southern Italy. Breast Cancer Res Treat 2001 1.02
23 Efficacy of two Ni-Ti systems and hand files for removing gutta-percha from root canals. Int Endod J 2011 0.99
24 Normocalcemia with elevated parathyroid hormone levels after surgical treatment of primary hyperparathyroidism. Am J Surg 2001 0.98
25 Metastases to the breast: role of fine needle cytology samples. Our experience with nine cases in 2 years. Ann Oncol 2007 0.98
26 Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res 1993 0.97
27 Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix. Gynecol Oncol 2011 0.97
28 Deregulation of HOX B13 expression in urinary bladder cancer progression. Curr Med Chem 2013 0.96
29 Expression and functional role of CRIPTO-1 in cutaneous melanoma. Br J Cancer 2011 0.96
30 Down-regulation of lysyl oxidase-induced tumorigenic transformation in NRK-49F cells characterized by constitutive activation of ras proto-oncogene. J Biol Chem 2001 0.95
31 Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort. Ann Oncol 2011 0.94
32 Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol 1998 0.94
33 Epidermal growth factor receptor in human breast cancer comparison with steroid receptors and other prognostic factors. Int J Biol Markers 1996 0.92
34 Designing a sub-set of the UMLS knowledge base applied to a clinical domain: methods and evaluation. Proc Annu Symp Comput Appl Med Care 1994 0.92
35 Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay. J Clin Oncol 2001 0.92
36 Knowledge acquisition from the UMLS sources: application to the description of surgical procedures. Medinfo 1995 0.91
37 Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor. Oncogene 1996 0.91
38 Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases. The Melanoma Cooperative Group. Br J Cancer 2000 0.91
39 Recording of monophasic action potentials of the right ventricle in long QT syndromes complicated by severe ventricular arrhythmias. Eur Heart J 1983 0.90
40 Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study. Br J Cancer 2006 0.89
41 Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours. J Pathol 2008 0.88
42 Sentinel node biopsy in head and neck cancer. Ann Surg Oncol 2001 0.88
43 Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I study. Ann Oncol 1997 0.88
44 Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy. Eur J Surg Oncol 2006 0.87
45 [A useful panel in proliferative urothelial lesions: an analysis of cytokeratin 20, p53, CD44 and Ki-67 antigens]. Pathologica 2007 0.87
46 Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene. Oncogene 1996 0.86
47 Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma. Ann Surg Oncol 2007 0.85
48 Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma. Br J Dermatol 2007 0.84
49 Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography. J Nucl Med 1996 0.83
50 Issues in the design of medical ontologies used for knowledge sharing. J Med Syst 2001 0.83
51 Sociodemographic factors associated with the diagnostic staging of breast cancer in southern Italy. Cancer 1995 0.83
52 Parallel determination of NeuroD1, chromogranin-A, KI67 and androgen receptor expression in surgically treated prostate cancers. Int Braz J Urol 2011 0.83
53 Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial. Br J Cancer 2006 0.83
54 Malignant melanoma of the nipple: a case studied with radiolabeled monoclonal antibody. Tumori 1991 0.82
55 Dilated cardiomyopathy with regional myocardial hypoperfusion in Becker's muscular dystrophy. Int J Cardiol 1989 0.82
56 Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting for MLH1 and MSH2 inactivation in familial cases. Ann Oncol 2003 0.82
57 Body surface maps in left bundle branch block uncomplicated or complicated by myocardial infarction, left ventricular hypertrophy or myocardial ischemia. J Electrocardiol 1987 0.81
58 Sentinel lymph node biopsy in patients with cutaneous melanoma: outcome after 3-year follow-up. Eur J Surg Oncol 2004 0.81
59 Changing patterns of breast cancer stage at diagnosis in southern italy: hospital data as indicators of progressive changes. Prev Med 2000 0.80
60 Vitronectin binding to urokinase receptor in human breast cancer. Clin Cancer Res 1997 0.80
61 The HOX genes network in uro-genital cancers: mechanisms and potential therapeutic implications. Curr Med Chem 2011 0.80
62 Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study. Ann Oncol 2012 0.80
63 Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study. Ann Oncol 2007 0.80
64 Cell-specific regulation of alpha1(III) and alpha2(V) collagen by TGF-beta1 in tubulointerstitial cell models. Nephrol Dial Transplant 1998 0.79
65 Neoadjuvant chemotherapy for intermediate/high-grade soft tissue sarcomas: five-year results with epirubicin and ifosfamide. Anticancer Res 2003 0.79
66 A reference standard for plasma proteins is required for nutritional assessment of adult burn patients. Burns 1998 0.79
67 Epithelioid cell-type melanoma as a prognostic factor of poor response to immunological treatment. Ann Oncol 2000 0.79
68 A 2-month cisplatin-epirubicin-paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study. Ann Oncol 2005 0.79
69 Thallium 201 for detection of viable myocardium: comparison of different reinjection protocols. J Nucl Cardiol 1998 0.79
70 [Efficacy of verapamil in the prevention of ventricular fibrillation in the acute phase of myocardial infarction]. Arch Mal Coeur Vaiss 1988 0.79
71 Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG). Ann Oncol 2000 0.78
72 [Effect of a new antiarrhythmic drug, bunaftine, on the bundle of His]. Cardiol Prat 1973 0.78
73 Augmentation cheiloplasty by using mucomuscular flaps. Aesthetic Plast Surg 1995 0.78
74 Postoperative self-expansion in augmentation mammaplasty. Plast Reconstr Surg 1994 0.78
75 Does a relationship exist between trends in estrogen receptor levels and breast cancer incidence and mortality? Int J Oncol 1998 0.78
76 Establishment and growth regulation of a novel ovarian cancer cell line from a poorly-differentiated adenocarcinoma: proposal for a new treatment. Eur J Gynaecol Oncol 1999 0.78
77 Ten homozygous-D-individuals in one Italian village. Hum Hered 1990 0.78
78 Dipyridamole echocardiography for diagnosis of coexistent coronary artery disease in hypertrophic cardiomyopathy. Echo-Persantine International Cooperative (EPIC) Study Group--Subproject Hypertrophic Cardiomyopathy. Am J Cardiol 1995 0.78
79 [Syndrome X]. Recenti Prog Med 1989 0.77
80 [Role of neoadjuvant chemotherapy in intermediate/high-grade soft-tissue sarcomas in the adult]. Tumori 2003 0.77
81 Relationship between HLA-DQ and -DR genotypes and clinical characteristics in a French population of Type 1 diabetic patients. Diabet Med 1999 0.77
82 Clinical significance of PCR-positive mRNA markers in peripheral blood and regional nodes of malignant melanoma patients. Melanoma Cooperative Group. Recent Results Cancer Res 2001 0.77
83 [Acute myocardial infarction in a case of obstructive cardiomyopathy of the left ventricle (author's transl)]. G Ital Cardiol 1978 0.77
84 [Early evaluation using PET-FDG of the efficiency of neoadjuvant radiochemotherapy treatment in locally advanced neoplasia of the lower rectum]. Tumori 2003 0.76
85 Commissure-based buccal mucosal flap. Plast Reconstr Surg 1999 0.75
86 Leiomyosarcoma of the Oropharynx and Neurogenic Tumors in a Young Patient With Turner's Syndrome. Sarcoma 2001 0.75
87 Can high-resolution ultrasound avoid the sentinel lymph-node biopsy procedure in the staging process of patients with stage I-II cutaneous melanoma? Ultraschall Med 2012 0.75
88 Invasive electrophysiological study in the Jervell and Lange-Nielsen syndrome. Br Heart J 1982 0.75
89 A collaborative approach to building a terminology for medical procedures using a Web-based application: from specifications to daily use. Stud Health Technol Inform 1998 0.75
90 [The clinical significance of signal-averaged electrocardiography in hypertrophic cardiomyopathy]. G Ital Cardiol 1990 0.75
91 Effects of interaction of quinidine and beta-blocking agents on some cardiodynamic and hemodynamic parameters of normal individuals. Am Heart J 1969 0.75
92 A program for expert diagnosis and therapeutic decision. Med Inform (Lond) 1983 0.75
93 [Role of cervical spondylosis in complicated angina pectoris]. Acta Biomed Ateneo Parmense 1983 0.75
94 [Autogenous transplant of canines impacted in bone]. Riv Odontostomatol Implantoprotesi 1983 0.75
95 Sentinel lymph node biopsy to stage patients with cutaneous melanoma at the National Cancer Institute of Naples. Results from 240 sentinel node biopsies. Tumori 2002 0.75
96 [Treatment of loco-regional lymph nodes in cutaneous melanoma]. Suppl Tumori 2002 0.75
97 Sentinel lymph node biopsy in atypical Spitz nevi: is it useful? Eur J Surg Oncol 2012 0.75
98 Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: a Southern Italy Cooperative Oncology Group phase I/II study. Semin Oncol 2001 0.75
99 [Prevention today: comparison between traditional techniques and television messages]. Riv Odontostomatol Implantoprotesi 1983 0.75
100 Outcome analysis of breast cancer patients receiving breast-conserving surgery in Southern Italy. J Chemother 2008 0.75
101 [Survival after gastrectomy for cancer. 209 cases]. Presse Med 1992 0.75
102 [The Clerc, Levy and Cristesco syndrome. II. Physiopathological study]. Folia Cardiol 1968 0.75
103 Preliminary report on electrophysiological effectiveness of creatinol O-phosphate (COP) in human subjects. Arzneimittelforschung 1979 0.75
104 Critical considerations on employing scatteres with electron beams accelerated by the Betatron. Strahlentherapie 1967 0.75
105 [Health education. A priority and basic problem]. G Ital Cardiol 1980 0.75
106 [Coronary fistulas. Description of a case of surgically corrected double fistula]. Minerva Cardioangiol 1978 0.75
107 [Comparative study on the cardiodynamic action of ajmaline and its dimonochloroacetylate derivative]. Rev Clin Esp 1969 0.75
108 [Volume and left ventricular mass in idiopathic dilated cardiomyopathy]. Minerva Cardioangiol 1987 0.75
109 [Supraventricular hyperkinetic arrhythmias in sick sinus syndrome. Clinical and electrophysiological evaluation]. G Ital Cardiol 1983 0.75
110 [Selective coronary scintiscanning]. G Ital Cardiol 1981 0.75
111 [Presentation of a system for computer-aided decision in diabetes therapeutics]. Pathol Biol (Paris) 1985 0.75
112 Modulation of human sperm function by follicular fluid. Andrologia 2004 0.75
113 [Origin of the left circumflex coronary artery from the right Valsalva sinus. Two cases with clinical and instrumental signs of coronary insufficiency (author's transl)]. G Ital Cardiol 1977 0.75
114 Severity of arrhythmias and extent of hypertrophy in hypertrophic cardiomyopathy. Am Heart J 1989 0.75
115 [Grave symptomatic forms of hypertrophic obstructive cardiomyopathy in childhood. Apropos of 5 operated cases]. G Ital Cardiol 1979 0.75
116 [Clinical investigation into the prophylactic and therapeutic action of Bunaftine in arrhythmias at the acute stage of myocardial infarction (author's transl)]. Ann Cardiol Angeiol (Paris) 1976 0.75
117 [A study of the mechanism of the action of Bunaphtine recording the myocardial monophasic action potentials in man. Conclusive report (author's transl)]. G Ital Cardiol 1976 0.75
118 Clinical significance of coronary artery disease in hypertrophic cardiomyopathy. Am J Cardiol 1992 0.75
119 [Analysis of parameters used for the evaluation of the Relative Complexity Index beta]. Ann Fr Anesth Reanim 1993 0.75
120 [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias]. G Ital Cardiol 1981 0.75
121 [Clinical pharmacology of anti-arrhythmic drugs and medical treatment of arrhythmias]. Atti Soc Ital Cardiol 1966 0.75
122 [Changes on release of MB isoenzyme of creatine kinase by propranolol in acute myocardial infarction (author's transl)]. G Ital Cardiol 1980 0.75
123 Uterine cervix carcinoma diagnosed during puerperium. Case report. Eur J Gynaecol Oncol 1990 0.75
124 Pneumatic dilatation in the treatment of achalasia. Int Surg 1985 0.75
125 [Use of body surface electromaps in the identification of malignant ventricular hyperkinetic arrhythmias]. G Ital Cardiol 1983 0.75
126 [Considerations on some problems in delimitation of high-energy electron beams]. Minerva Fisiconucl 1966 0.75
127 [Use of 17,21-di-monochloroacetyl-ajmaline in the prevention and therapy of arrhythmia caused by myocardial hyperexcitability]. Minerva Med 1970 0.75
128 Uterine carcinosarcoma. Case report. Eur J Gynaecol Oncol 1989 0.75
129 [Prognostic value of extensive lymph node excision in curative resections of stomach cancers. Apropos of a series of 100 patients]. Chirurgie 1996 0.75
130 [Hemodynamic changes after left ventriculography]. Boll Soc Ital Cardiol 1976 0.75
131 [Tricuspid endocarditis caused by Staphylococcus aureus in AIDS. Discussion of a case]. G Ital Cardiol 1988 0.75
132 [Variability of ventricular extrasystole in non-heart disease patients and subjects with previous myocardial infarct]. Boll Soc Ital Cardiol 1981 0.75
133 [The campaign against arterial hypertension]. G Ital Cardiol 1983 0.75
134 Assessment of multidrug resistance (MDR) by immunohistochemistry in breast carcinoma. Correlation with tumor size and regional node status. J Nucl Med Allied Sci 1991 0.75
135 Tumour uptake of 57-cobalt-bleomycin in patients with breast cancer. Eur J Cancer 1993 0.75
136 Breast cancer estrogen and progesterone receptors. Int J Oncol 1996 0.75
137 Diagnostic value of body surface maps in left bundle-branch block. Adv Cardiol 1981 0.75
138 The use of adhesive tape to inform the patient preoperatively. Plast Reconstr Surg 1989 0.75
139 The future of face lifts: a comparison between traditional surgery and advanced techniques. Facial Plast Surg 1996 0.75
140 Activation of COL3A1 promoter activity by cyclosporine. Transplant Proc 1998 0.75
141 [On the anti-arrhythmia activity of a new adrenergic blocking agent]. Cardiologia 1966 0.75
142 [Guanethidine and thyrotoxicosis. Influence of prolonged treatment on hemodynamic indexes]. Folia Cardiol 1969 0.75
143 [A case of peritoneal tuberculosis. Contribution of mini-endoscopy]. Minerva Ginecol 1999 0.75
144 Primary carcinoma of the vagina. Case report. Eur J Gynaecol Oncol 1990 0.75
145 [Anesthetists and continuing education]. Ann Fr Anesth Reanim 1994 0.75
146 [Experimental study on the action of a new beta-adrenergic blocking agent, hydrobutamine, in digitalis-induced arrhythmias]. Folia Cardiol 1966 0.75
147 [Polycentric clinical experimentation with a new anti-arrhythmia agent: bunaftide]. Boll Soc Ital Cardiol 1972 0.75
148 Retinoic acid receptors alpha, beta and gamma, and cellular retinol binding protein-I expression in breast fibrocystic disease and cancer. Eur J Endocrinol 1997 0.75
149 Endoscopy in facial rejuvenation. Plast Reconstr Surg 1997 0.75
150 Low doses interferon-alpha in the treatment of high-risk cutaneous melanoma. Melanoma Cooperative Group. Ann Oncol 2000 0.75
151 [Experimental characterization of propafenone. Hemodynamic effects]. G Ital Cardiol 1984 0.75
152 [Identification using thoracic electromapping of patients with sustained postinfarct ventricular tachycardia. Preliminary results of a new method of analysis of ST-T isoarea maps]. G Ital Cardiol 1987 0.75
153 Subcutaneous sacrococcygeal myxopapillary ependymoma. A case report. Eur J Cancer 1994 0.75
154 [Trials in several centers of aluminium glycyrrhetate in the therapy of ulcer disease]. Minerva Med 1969 0.75
155 Surgery possibilities for laryngeal and hypopharyngeal carcinomas after treatment with high-energy betatron electrons. Acta Otolaryngol 1966 0.75
156 [The Clerc, Levy and Cristesco syndrome. I. Clinical and electrocardiographic study]. Folia Cardiol 1968 0.75
157 [Verapamil in acute myocardial infarct. Hemodynamic effects and electrical changes studied by means of electromaps of the chest]. Boll Soc Ital Cardiol 1981 0.75
158 [Experimental study of the anti-arrhythmic action of a new beta-adrenergic blocking agent: hydrobutamine]. Folia Cardiol 1966 0.75
159 [Effects of Bunaphtine on right atrial and ventricular monophasic action potentials in man. Preliminary note (author's transl)]. G Ital Cardiol 1976 0.75
160 [Importance of recording the human monophasic action potential]. G Ital Cardiol 1980 0.75
161 [Validity and limits of invasive pharmacological tests in the treatment of malignant ventricular hyperkinetic arrhythmias]. G Ital Cardiol 1983 0.75
162 Thick skin and cosmetic surgery of the nasal tip: how to avoid the cutaneous polly beak. Aesthetic Plast Surg 1996 0.75
163 [Effects of the association of potassium and a beta-adrenergic blocking agent (butidrine) on normal cardiac rhythm and on experimental arrhythmias caused by adrenaline and aconitine in the rabbit]. Minerva Cardioangiol 1966 0.75
164 [Junctional bradycardia and junctional non-paroxysmal tachycardia. A study with atrial and His electrogram and influence of neurovegetative system (author's transl)]. G Ital Cardiol 1975 0.75
165 [Acute isolated infarct of the right ventricle with an unusual hemodynamic and electrocardiographic pattern]. G Ital Cardiol 1987 0.75
166 [1st experimental results on antiarrhythmic activity of an acetylated derivative of ajmaline: dichloro-acetyl-ajmaline]. Boll Soc Ital Cardiol 1966 0.75
167 [Blood loss from diagnostic laboratory tests performed in intensive care units. Preliminary study]. Ann Fr Anesth Reanim 1996 0.75
168 Impressive lung uptake during exercise thallium imaging with decrease of systolic blood pressure. Eur Heart J 1987 0.75
169 [Polyomavirus BK-associated nephropathy after kidney transplantation]. G Ital Nefrol 2006 0.75
170 [Treatment of acute myocardial infarction with verapamil. Hemodynamic effects and electrical changes studied by body surface maps (author's transl)]. G Ital Cardiol 1981 0.75
171 [Carotid artery occlusion disclosed by cerebral ischemia. Lesional, etiologic and developing aspects]. Ann Med Interne (Paris) 1990 0.75
172 Efficacy and tolerability of gallopamil in coronary heart disease: a double blind cross-over comparison with nifedipine. Eur Heart J 1992 0.75
173 Characterization of a DNA binding site that mediates the stimulatory effect of cyclosporin-A on type III collagen expression in renal cells. Nephrol Dial Transplant 2000 0.75
174 [Quantitative viremia and p24 antigenemia in short-term follow-up of the treatment with zidovudine in twenty HIV infected patients]. Pathol Biol (Paris) 1993 0.75
175 Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes. Eur Heart J 1985 0.75
176 The ret protooncogene is expressed in predominantly epithelial human thymomas. Int J Oncol 1994 0.75
177 [Comparison of the dubious exercise test and coronarography]. Boll Soc Ital Cardiol 1977 0.75
178 [Stratigraphic study of adenoid vegetations in the rhinopharynx of children]. Otorinolaringol Ital 1966 0.75
179 [Validity of the study of the electrophysiological effects of anti-arrhythmia drugs in man prior to modern antiarrhythmic therapy. Multicenter study]. Boll Soc Ital Cardiol 1980 0.75
180 [Electrophysiological effects of lidocaine on the QRS and ST segment during acute myocardial infarct. Evaluation with thoracic electromaps]. G Ital Cardiol 1982 0.75
181 [Effect of the stimulation of H2 receptors by impromidine in patients with idiopathic dilated cardiomyopathy]. Cardiologia 1987 0.75
182 Chemotherapy in squamous cell carcinoma of the cervix uteri: present role and perspectives. Cancer Treat Rev 1998 0.75
183 [Comparison of indices of hemodynamic evaluation of the function of the left ventricle]. G Ital Cardiol 1983 0.75
184 [Coronary disease during primary hyperuricemia]. Boll Soc Ital Cardiol 1976 0.75
185 [Systolic time intervals in acute myocardial infarction]. G Ital Cardiol 1972 0.75
186 In vitro receptor imaging for characterization of human solid tumors. Nucl Med Biol 1994 0.75
187 [Ischemic and non ischemic electrophysiologic changes during selective coronary arteriography. Their role in the pathogenesis of the electrocardiographic changes and arrhythmias (author's transl)]. G Ital Cardiol 1980 0.75
188 Expression of CD40 has no predictive value in soft tissue sarcomas. Anticancer Res 2003 0.75
189 [Changes in the urinary excretion of VMA (vanilmandelic acid) in patients with hyperthyroidism treated chronically with guanethidine]. Clin Ter 1969 0.75
190 Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled study. J Viral Hepat 2003 0.75
191 Isolated hypertrophic obstructive cardiomyopathy of the right ventricle. G Ital Cardiol 1979 0.75
192 [Clinico-pharmacological study on the cardiodynamic interaction between digitalis and the adrenergic beta blockader butidrine]. Clin Ter 1968 0.75
193 [Influence of long-term treatment with guanethidine on the clinical symptoms and specific thyroid functional indices during thyrotoxicosis]. G Clin Med 1968 0.75
194 [Anomalous origin of the left coronary from the trunk of the pulmonary artery. Description of a clinical case]. G Ital Cardiol 1987 0.75
195 [Comparative study on the cardiodynamic action of ajmaline and its dimonochloroacetylate derivative]. Clin Ter 1968 0.75
196 Radiation dose to the lenses in CT of the paranasal sinuses. Neuroradiology 1996 0.75
197 Plasma fibronectin: a study of 340 assays. Int J Tissue React 1990 0.75